Literature DB >> 22487974

Surgical management of metastatic spinal tumors.

I Laufer1, D M Sciubba, M Madera, A Bydon, T J Witham, Z L Gokaslan, J-P Wolinsky.   

Abstract

BACKGROUND: The spine is the most common site of skeletal metastases. The evolution of surgical methods, medical treatment, and radiation therapy has led to improved survival, functional status, and quality of life for patients with cancer. The role of surgery in the treatment of patients with spinal metastases has evolved over time.
METHODS: A review of publications describing the role of open surgery and vertebroplasty was performed and the results are summarized.
RESULTS: The treatment goals of spinal metastases include the preservation and restoration of neurologic function and spinal stability. Modern imaging modalities provide accurate methods of tumor diagnosis. A variety of approaches and stabilization techniques are available and should be tailored to the location of the tumor and systemic comorbidities.
CONCLUSIONS: As part of multidisciplinary treatment that includes radiation therapy and chemotherapy, surgery provides an effective method of restoration and preservation of neurologic function and spinal stability for patients with metastatic spinal tumors.

Entities:  

Mesh:

Year:  2012        PMID: 22487974     DOI: 10.1177/107327481201900206

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  29 in total

1.  Prolonged survival following aggressive treatment for metastatic breast cancer in the spine.

Authors:  Patricia L Zadnik; Lee Hwang; Derek G Ju; Mari L Groves; Jackson Sui; Alp Yurter; Timothy F Witham; Ali Bydon; Jean-Paul Wolinsky; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Clin Exp Metastasis       Date:  2013-09-03       Impact factor: 5.150

2.  OPF/PMMA cage system as an alternative approach for the treatment of vertebral corpectomy.

Authors:  Asghar Rezaei; Hugo Giambini; Alan L Miller; Xifeng Liu; Benjamin D Elder; Michael J Yaszemski; Lichun Lu
Journal:  Appl Sci (Basel)       Date:  2020-10-02       Impact factor: 2.679

Review 3.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.

Authors:  Zach Pennington; A Karim Ahmed; Camilo A Molina; Jeffrey Ehresman; Ilya Laufer; Daniel M Sciubba
Journal:  Ann Transl Med       Date:  2018-03

4.  Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases.

Authors:  Shuai Han; Ting Wang; Dongjie Jiang; Yang Yu; Yu Wang; Wangjun Yan; Wei Xu; Ming Cheng; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

5.  A validation of the Oswestry Spinal Risk Index.

Authors:  S Whitehouse; J Stephenson; V Sinclair; J Gregory; A Tambe; R Verma; Irfan Siddique; Mohammad Saeed
Journal:  Eur Spine J       Date:  2014-11-13       Impact factor: 3.134

Review 6.  Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing.

Authors:  Cynthia Campbell-Baird; Stacey Harrelson; Georgette Frey; Arun Balakumaran
Journal:  Support Care Cancer       Date:  2015-08-23       Impact factor: 3.603

Review 7.  Diagnosis and surgical management of breast cancer metastatic to the spine.

Authors:  Derek G Ju; Alp Yurter; Ziya L Gokaslan; Daniel M Sciubba
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 8.  Current trends in mini-invasive management of spine metastases.

Authors:  Gianluigi Guarnieri; Roberto Izzo; Mario Muto
Journal:  Interv Neuroradiol       Date:  2015-05-11       Impact factor: 1.610

Review 9.  Acute Lumbar Back Pain.

Authors:  Hans-Raimund Casser; Susann Seddigh; Michael Rauschmann
Journal:  Dtsch Arztebl Int       Date:  2016-04-01       Impact factor: 5.594

10.  [Results-adapted operative treatment options for spinal metastases].

Authors:  C E Heyde; J Gulow; N von der Höh; A Völker; D Jeszenszky; U Weber
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.